R360Q (p.Arg360Gln) variant of AGXT (P21549)
R360Q (p.Arg360Gln) in AGXT (P21549) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of not provided; Primary hyperoxaluria, type I. The available variant effect predictions contribute to a CATVariant prioritization score of 0.91 / 1. The record also includes population frequency data, experimental measurements, published literature, and structural context.
R360Q (p.Arg360Gln) variant details
- p.Arg360Gln
- rs180177161
- ClinGen CA275783
- ClinVar RCV000186354
- ClinVar RCV001857592
- Pathogenic/Likely pathogenic
- not provided; Primary hyperoxaluria, type I
- Missense
- Variant Prioritization Score for Impact Estimate 0.913
- REVEL 0.95
- ESM-1b 1.00
- AlphaMissense 0.89
- MetaLR 0.98
- MetaSVM 1.04
- CADD 27.70
- ClinVar: Pathogenic/Likely pathogenic (not provided; Primary hyperoxaluria, type I)
- EBI: Pathogenic
- UniProt: Pathogenic
- Most common in the Non-Finnish European population (allele frequency 1.4e-05)
- Structural context available
- AGXT complementation assay *2 B: score -0.0033
- Cited in: Primary Hyperoxaluria Type 1. (PMID 20301460)
- Cited in: Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. (PMID 22547750)